Ignite Creation Date:
2024-05-06 @ 1:50 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04146571
Status:
AVAILABLE
Last Update Posted:
2022-10-20
First Post:
2019-10-28
Brief Title:
Expanded Access to Ensartinib for Participants With ALK NSCLC
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2019-10-28
First Submit QC Date:
October 28 2019
Study First Post Date:
2019-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-18
Last Update Post Date:
2022-10-20
Last Update Post Date Type:
ACTUAL